PharVision Advisers LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

PharVision Advisers LLC purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,807 shares of the company's stock, valued at approximately $251,000.

Several other institutional investors have also added to or reduced their stakes in the business. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health in the fourth quarter worth about $26,000. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its stake in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. purchased a new position in shares of Option Care Health in the fourth quarter worth about $47,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on OPCH. JMP Securities restated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. JPMorgan Chase & Co. raised their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Stock Down 2.1%

Option Care Health stock opened at $32.03 on Friday. The stock has a market capitalization of $5.24 billion, a PE ratio of 26.92, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The business has a 50 day simple moving average of $33.05 and a 200-day simple moving average of $29.24. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business's revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.26 earnings per share. On average, analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Activity

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.